rs73505326
Variant names: 
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000590627.5(GCDH):n.902G>A variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0095 in 1,592,658 control chromosomes in the GnomAD database, including 1,291 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
 Genomes: 𝑓 0.050   (  667   hom.,  cov: 31) 
 Exomes 𝑓:  0.0052   (  624   hom.  ) 
Consequence
 GCDH
ENST00000590627.5 non_coding_transcript_exon
ENST00000590627.5 non_coding_transcript_exon
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -0.0570  
Publications
1 publications found 
Genes affected
 GCDH  (HGNC:4189):  (glutaryl-CoA dehydrogenase) The protein encoded by this gene belongs to the acyl-CoA dehydrogenase family. It catalyzes the oxidative decarboxylation of glutaryl-CoA to crotonyl-CoA and CO(2) in the degradative pathway of L-lysine, L-hydroxylysine, and L-tryptophan metabolism. It uses electron transfer flavoprotein as its electron acceptor. The enzyme exists in the mitochondrial matrix as a homotetramer of 45-kD subunits. Mutations in this gene result in the metabolic disorder glutaric aciduria type 1, which is also known as glutaric acidemia type I. Alternative splicing of this gene results in multiple transcript variants. A related pseudogene has been identified on chromosome 12. [provided by RefSeq, Mar 2013] 
GCDH Gene-Disease associations (from GenCC):
- glutaryl-CoA dehydrogenase deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet, G2P, Myriad Women’s Health
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.71). 
BP6
Variant 19-12893685-G-A is Benign according to our data. Variant chr19-12893685-G-A is described in ClinVar as Benign. ClinVar VariationId is 255396.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.172  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| GCDH | NM_000159.4 | c.505+32G>A | intron_variant | Intron 6 of 11 | ENST00000222214.10 | NP_000150.1 | ||
| GCDH | NM_013976.5 | c.505+32G>A | intron_variant | Intron 6 of 11 | NP_039663.1 | |||
| GCDH | NR_102316.1 | n.668+32G>A | intron_variant | Intron 6 of 11 | ||||
| GCDH | NR_102317.1 | n.921+32G>A | intron_variant | Intron 5 of 10 | 
Ensembl
Frequencies
GnomAD3 genomes  0.0502  AC: 7633AN: 152102Hom.:  668  Cov.: 31 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
7633
AN: 
152102
Hom.: 
Cov.: 
31
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.0131  AC: 3296AN: 250810 AF XY:  0.00952   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
3296
AN: 
250810
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.00521  AC: 7499AN: 1440438Hom.:  624  Cov.: 26 AF XY:  0.00441  AC XY: 3164AN XY: 717740 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
7499
AN: 
1440438
Hom.: 
Cov.: 
26
 AF XY: 
AC XY: 
3164
AN XY: 
717740
show subpopulations 
African (AFR) 
 AF: 
AC: 
6136
AN: 
33048
American (AMR) 
 AF: 
AC: 
419
AN: 
44702
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
26026
East Asian (EAS) 
 AF: 
AC: 
1
AN: 
39610
South Asian (SAS) 
 AF: 
AC: 
18
AN: 
85842
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
52850
Middle Eastern (MID) 
 AF: 
AC: 
32
AN: 
5690
European-Non Finnish (NFE) 
 AF: 
AC: 
213
AN: 
1093004
Other (OTH) 
 AF: 
AC: 
680
AN: 
59666
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.489 
Heterozygous variant carriers
 0 
 325 
 650 
 974 
 1299 
 1624 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 188 
 376 
 564 
 752 
 940 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.0501  AC: 7632AN: 152220Hom.:  667  Cov.: 31 AF XY:  0.0485  AC XY: 3606AN XY: 74426 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
7632
AN: 
152220
Hom.: 
Cov.: 
31
 AF XY: 
AC XY: 
3606
AN XY: 
74426
show subpopulations 
African (AFR) 
 AF: 
AC: 
7286
AN: 
41496
American (AMR) 
 AF: 
AC: 
248
AN: 
15290
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3468
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5180
South Asian (SAS) 
 AF: 
AC: 
1
AN: 
4830
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10620
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
24
AN: 
68018
Other (OTH) 
 AF: 
AC: 
73
AN: 
2112
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.500 
Heterozygous variant carriers
 0 
 311 
 621 
 932 
 1242 
 1553 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 68 
 136 
 204 
 272 
 340 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
34
AN: 
3478
ClinVar
Significance: Benign 
Submissions summary: Benign:3 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not provided    Benign:2 
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
not specified    Benign:1 
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.